Articles

Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations

Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nagano Red Cross Hospital, Tokyo, Japan
Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Japan
Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Japan
Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan
Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan
Division of Hematology, Saitama Medical Center Jichi Medical University, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
Department of Hematology, Nippon Medical School, Tokyo, Japan
Vol. 101 No. 9 (2016): September, 2016 https://doi.org/10.3324/haematol.2016.143073